Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
published in: The Lancet
date of publication: 2013-10-26
language: English
main subject: adalimumab, rheumatoid arthritis, methotrexate
Cites articles 38
- 2000-12-01
Date
Title
Article - wd:Q46048883